UK gets £100m stem cell boost
By The Register,
The Register
| 12. 02. 2005
The UK's stem cell research programmes will benefit from £100m over the next two years after Gordon Brown doubled the government's financial committement to the technology, Reuters reports. Brown said the cash would go to "pre-commercial aspects of stem cell research" - considered high-risk by pharmaceutical companies - and the recently-established UK Stem Cell Foundation.
More specifically, the money was destined for "clinical trials within the state health service, research into cell production facilities" and support for the UK's stem cell bank.
Brown said at an enterprise conference in London: "Britain should be the world's number one centre for genetic and stem cell research, building on our world leading regulatory regime in the area."
The UK has already adopted a rigourous pro-research stance in the face of widespread opposition to the technology. Back in March, it declared it would ignore a non-binding UN ban on human cloning, at least as far as therapeutic cloning is concerned. Health secretary John Reid noted: "Reproductive cloning is already illegal in the UK. Anyone attempting it in this country faces a 10-year prison sentence...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...